论文部分内容阅读
药品质量事关国计民生,我国药品研发起步较晚,历史原因造成了部分已上市药品在质量和疗效方面与欧美日等跨国制药公司的产品存在一定差距。经历数十年的发展,我国已基本解决老百姓用药可及性难题,已经不再是缺医少药的年代,随着人们生活质量提升,药品质量提升也迫在眉睫。为落实《国家药品安全“十二五”规划》中全面提高仿制药质量的工作部署,
The quality of medicines is related to people’s livelihood and the people’s livelihood in our country. Late development of pharmaceuticals in our country led to some gaps in the quality and efficacy of some listed medicines with the products of multinational pharmaceutical companies such as Europe, the United States and Japan. After decades of development, China has basically solved the problem of access to medicines for the common people. It is no longer an era of lack of medical treatment and less medicine. With the improvement of people’s quality of life, the quality of medicines is also imminent. In order to implement the work plan of comprehensively improving the quality of generics in the “Twelfth Five-Year Plan” of “National Drug Safety”